180
Participants
Start Date
August 31, 2004
Primary Completion Date
April 30, 2011
Study Completion Date
April 30, 2011
risperidone
Risperidone open label flexible dose 0.25 to 3 mg daily for first 16 weeks; dose at 16 weeks then fixed for randomized trial
Mount Sinai School of Medicine, Alzheimer's Disease Research Center, New York
New York State Psychiatric Institute, Columbia University, New York
Medical University of South Carolina, North Charleston
Tuscaloosa VA Medical Center, Department of Psychiatry, Tuscaloosa
University of Iowa College of Medicine, Iowa City
WLA VA Medical Center/UCLA, Psychiatry, Los Angeles
Research Center for Clinical Studies, Inc., Norwalk
National Institute on Aging (NIA)
NIH
Columbia University
OTHER
New York State Psychiatric Institute
OTHER